Literature DB >> 15931541

Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy.

H J Zambarakji1, S Ghazi-Nouri, M Schadt, C Bunce, P G Hykin, D G Charteris.   

Abstract

BACKGROUND: Central retinal vein occlusion (CRVO) is a common retinal vascular disorder and a leading cause of visual loss. It is thought to arise from vascular obstruction at the level of the lamina cribrosa. The purpose of the study reported here was to evaluate the potential benefit of radial optic neurotomy (RON) and determine its effect on foveal thickness and macular volume in patients with CRVO.
METHODS: We conducted a prospective pilot study of ten patients with CRVO. Visual acuity (VA) score measured with the Early Treatment Diabetic Retinopathy Study chart and the corresponding Snellen equivalent were assessed before and 6 months after surgery. Colour fundus photography, fluorescein angiography (FA) and optical coherence tomography (OCT) were carried out before and at 2, 6, 12 and 24 weeks after surgery. Foveal thickness and macular volumes were assessed using OCT.
RESULTS: Visible reperfusion was observed in four of the ten patients at the time of surgery. VA score improved in eight of the ten patients from a median score of 11.50 (range 0-68) to a median score of 35.00 (range 3-79). Macular volumes decreased in six of seven patients from a median of 4.99 mm3 (range 2.68-6.77) to a median of 3.11 mm3 (range 1.11-5.02). Foveal thickness decreased in six of seven patients from a median of 596.50 microm (range 338.50-745.50) to a median of 330.50 microm (range 118-634.50). Six of ten patients developed a chorioretinal venous anastomosis. Macular oedema on OCT persisted in six of ten patients.
CONCLUSIONS: We observed an improvement in VA score and a corresponding reduction in foveal thickness and macular volume following RON, but macular oedema persisted in 60% of patients. Whilst optimisation of patient selection criteria remains a challenge, this pilot study suggests that RON has a beneficial effect on VA in patients presenting with CRVO.

Entities:  

Mesh:

Year:  2004        PMID: 15931541     DOI: 10.1007/s00417-004-1046-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

Authors:  Paul B Greenberg; Adam Martidis; Adam H Rogers; Jay S Duker; Elias Reichel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases.

Authors:  E M Opremcak; R A Bruce; M D Lomeo; C D Ridenour; A D Letson; A J Rehmar
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1997-04

4.  A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

Authors:  L L Hansen; J Wiek; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

5.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion.

Authors:  Josée García-Arumíi; Anna Boixadera; Vicente Martinez-Castillo; Reinaldo Castillo; Antonio Dou; Borja Corcostegui
Journal:  Arch Ophthalmol       Date:  2003-10

7.  Baseline and early natural history report. The Central Vein Occlusion Study.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-08

8.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

9.  Streptokinase in central retinal vein occlusion: a controlled clinical trial.

Authors:  E M Kohner; J E Pettit; A M Hamilton; C J Bulpitt; C T Dollery
Journal:  Br Med J       Date:  1976-03-06

10.  Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-05
View more
  6 in total

Review 1.  Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

Review 3.  Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Kristina Lindsley; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2014-05-01

4.  [Radial optic neurotomy: efficacy monitoring using venous ophthalmodynamometry].

Authors:  M Rauber; S Müller; U Mester
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

5.  SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; J Michael Jumper; Maria Figueroa
Journal:  Ophthalmology       Date:  2009-01-22       Impact factor: 12.079

6.  Radial optic neurotomy: a new surgical approach for glaucoma treatment?

Authors:  Ruth E Rosenstein; Nicolás Belforte
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.